These outcomes, together with a prior report exhibiting that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,two aid the principle of targeting ACKR3 as a novel strategy to modulate the opioid process, which could open new therapeutic avenues for opioid-related disorders. By ticking this box and submitting https://kennethg517zcg9.national-wiki.com/user